e-learning
resources
Barcelona 2013
Monday, 09.09.2013
Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Finding asthmatics suitable for omalizumab therapy in a district hospital
S. M. Tariq, P. Kanthapillai, F. Parkar (Luton, United Kingdom)
Source:
Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Session:
Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Session type:
Poster Discussion
Number:
2025
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. M. Tariq, P. Kanthapillai, F. Parkar (Luton, United Kingdom). Finding asthmatics suitable for omalizumab therapy in a district hospital. Eur Respir J 2013; 42: Suppl. 57, 2025
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Respiratory sequelae of preterm birth across the life span
Time to breathe: Challenges in the successful management of asthma during conception, pregnancy and delivery
Related content which might interest you:
Prevalence of refractory asthma in population with severe asthma
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Patients with allergic and eosinophilic asthma in the German severe asthma registry
Source: International Congress 2015 – Asthma and lung immunology
Year: 2015
A case diagnoed ACOS with omelizumab treatment
Source: International Congress 2016 – Clinical characteristics of asthma
Year: 2016
Serious asthma exacerbations in a hospital setting
Source: International Congress 2014 – Asthma: clinical problems
Year: 2014
Clinical outcomes in non-eosinophilic versus eosinophilic asthma after 12 months specialist management
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015
Prevalence of asthma and management of exacerbations in general practice (GP) after computerised Spanish guideline on the management of asthma (GEMA) and collaborative care environment
Source: International Congress 2015 – Management of asthma and COPD in primary care
Year: 2015
Comparison of clinical features of severe persistent asthma and refractory asthma
Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment?
Year: 2013
Prevalence of asthma symptoms, diagnosis and treatment use in Romania
Source: Annual Congress 2013 –Treatment and adherence to treatment of respiratory disease
Year: 2013
Guideline adherence and cost of asthma treatment at emergency department
Source: International Congress 2014 – Paediatric asthma: pharmacological and non-pharmacological management
Year: 2014
Management of asthma in patients discharged from A and E
Source: International Congress 2016 – Asthma points to ponder
Year: 2016
Use of beta-agonist therapy prior to hospital attendance for severe exacerbations of asthma
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Prevalence of allergic bronchopulmonary aspergillosis in patients with uncontrolled asthma: An experience from southwestern Iran
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015
Safety of sputum monitoring in a severe asthma population - The Manchester severe asthma team experience
Source: International Congress 2016 – Assessing lower airway inflammation with different tools
Year: 2016
Asthma control, symptoms and exacerbations across treatment levels in patients with asthma
Source: Annual Congress 2013 –Management of respiratory diseases in primary care
Year: 2013
Duration of inhaled corticosteroid therapy in children with asthma and frequency of community-acquired pneumonia in them
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016
P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients
Source: International Congress 2016 – Asthma management
Year: 2016
Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
Source: International Congress 2014 – More paediatric asthma
Year: 2014
Determinants of non-adherence to pharmacologic allergic rhinitis treatment
Source: Annual Congress 2013 –Treatment and management of asthma in primary care
Year: 2013
Acute exacerbations of asthma in Barcelona, the recent experience
Source: Annual Congress 2013 –Epidemiology of asthma
Year: 2013
The asthma-COPD, overlap syndrome, our clinical experience
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept